LoginSign Up
Antheia (Company)

Antheia (Company)

Antheia is an American biotechnology company founded in 2013, and is located in Menlo Park, California. Antheia uses synthetic biology, informatics, and fermentation technologies to produce plant based medicines; most notably opioids using yeast.

Antheia is an American biotechnology company founded in 2013, and is located in Menlo Park, California. Antheia uses synthetic biology, informatics, and fermentation technologies to produce plant based medicines; most notably opioids using yeast.

Grants

National Science Foundation

Antheia was awarded two grants by the National Science Foundation (NSF): 1) SBIR Phase I: production of plant alkaloid therapeutics via fermentation of engineered yeast on June 20, 2016 with a value of $225,000, and 2) SBIR Phase II: A complete bioprocess for medicinal plant opioids on March 5, 2018 with a value of $733,952.

National Institutes of Health

In 2017 Antheia received two grant awards, the Small Business and Innovation Research (SBIR) award and the Small Business Technology Transfer (STTR) award, from the National Institutes of Health (NIH) worth a total of $450,000.

Funding

Seed

On March 13, 2015 Antheia completed their seed funding round raising $1.97 million.

Series A

On May 26, 2017 Antheia completed their series A funding round raising $6,223,389.

Timeline

Received SBIR Phase II award from the National Science Foundation

On March 5, 2018 Antheia was awarded an SBIR Phase II grant titled "A complete bioprocess for medicinal plant opioids" from the National Science Foundation worth $733,952.

Series A funding round

On May 26, 2017 Antheia completed their series A funding round raising $6,223,389.

Received SBIR Phase I award from the National Science Foundation

Antheia received an SBIR Phase I grant from the National Science Foundation titled "Production of plant alkaloid therapeutics via fermentation of engineered yeast" on June 20, 2016 with a value of $225,000.

Seed funding round

On March 13, 2015 Antheia completed their seed funding round raising $1.97 million.

People

Name
Role
Related Golden topics

Christina Smolke

Co-founder , CEO, and President

Isis Trenchard

Co-founder

Kate Thodey

Co-founder

Kristy Hawkins

Co-founder

Ram Shiram

Board member

Further reading

Title
Author
Link
Type

Can This Silicon Valley Startup Bioengineer A Less Addictive Opioid?

Mark Sullivan

Christina Smolke: Fermenting revolution

Erika Check Hayden

New Bioengineering Method Could Change the Way Essential Medicines Are Produced

Glenn McDonald

Documentaries, videos and podcasts

Title
Date
Link

Opioids and Oxytocin Synthesized from Yeast?

August 15, 2015

Companies

Company
CEO
Location
Products/Services

References